| Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 1498 | 2015 |
| CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment N Mattsson, H Zetterberg, O Hansson, N Andreasen, L Parnetti, ... Jama 302 (4), 385-393, 2009 | 1416 | 2009 |
| An in vitro model for neuroscience: differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons L Agholme, T Lindström, K Kågedal, J Marcusson, M Hallbeck Journal of Alzheimer's Disease 20 (4), 1069-1082, 2010 | 551 | 2010 |
| Tau and Aβ42 in cerebrospinal fluid from healthy adults 21–93 years of age: establishment of reference values M Sjogren, H Vanderstichele, H Ågren, O Zachrisson, M Edsbagge, ... Clinical chemistry 47 (10), 1776-1781, 2001 | 522 | 2001 |
| The effect of age on the activity and molecular properties of human brain monoamine oxidase CJ Fowler, Å Wiberg, L Oreland, J Marcusson, B Winblad Journal of neural transmission 49 (1-2), 1-20, 1980 | 428 | 1980 |
| Transmitter deficits in Alzheimer's disease J Hardy, R Adolfsson, I Alafuzoff, G Bucht, J Marcusson, P Nyberg, ... Neurochemistry International 7 (4), 545-563, 1985 | 399 | 1985 |
| CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma S Neselius, H Brisby, A Theodorsson, K Blennow, H Zetterberg, ... PloS one 7 (4), 2012 | 336 | 2012 |
| Improved client participation in the rehabilitation process using a client-centred goal formulation structure E Wressle, AM Eeg-Olofsson, J Marcusson, C Henriksson Journal of rehabilitation medicine 34 (1), 5-11, 2002 | 315 | 2002 |
| The cerebrospinal fluid “Alzheimer profile”: easily said, but what does it mean? FH Duits, CE Teunissen, FH Bouwman, PJ Visser, N Mattsson, ... Alzheimer's & Dementia 10 (6), 713-723. e2, 2014 | 312 | 2014 |
| Spreading of neurodegenerative pathology via neuron-to-neuron transmission of β-amyloid S Nath, L Agholme, FR Kurudenkandy, B Granseth, J Marcusson, ... Journal of Neuroscience 32 (26), 8767-8777, 2012 | 302 | 2012 |
| Age‐correlated loss of dopaminergic binding sites in human basal ganglia JA Severson, J Marcusson, B Winblad, CE Finch Journal of neurochemistry 39 (6), 1623-1631, 1982 | 271 | 1982 |
| Age and diagnostic performance of Alzheimer disease CSF biomarkers N Mattsson, E Rosen, O Hansson, N Andreasen, L Parnetti, M Jonsson, ... Neurology 78 (7), 468-476, 2012 | 200 | 2012 |
| APOE ε4 allele is associated with reduced cerebrospinal fluid levels of Aβ42 JA Prince, H Zetterberg, N Andreasen, J Marcusson, K Blennow Neurology 62 (11), 2116-2118, 2004 | 198 | 2004 |
| Detection of dementia in primary care: the Linköping study M Ólafsdóttir, I Skoog, J Marcusson Dementia and geriatric cognitive disorders 11 (4), 223-229, 2000 | 190 | 2000 |
| Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims B Arranz, A Eriksson, E Mellerup, P Plenge, J Marcusson Biological psychiatry 35 (7), 457-463, 1994 | 189 | 1994 |
| High affinity [3H] paroxetine binding to serotonin uptake sites in human brain tissue I Ba, M Bergstro, J Marcusson Brain research 486 (2), 261-268, 1989 | 184 | 1989 |
| Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims RF Cowburn, JO Marcusson, A Eriksson, B Wiehager, C O'Neill Brain research 633 (1-2), 297-304, 1994 | 173 | 1994 |
| Spreading of amyloid-β peptides via neuritic cell-to-cell transfer is dependent on insufficient cellular clearance J Domert, SB Rao, L Agholme, AC Brorsson, J Marcusson, M Hallbeck, ... Neurobiology of disease 65, 82-92, 2014 | 171 | 2014 |
| Alzheimers sjukdom och andra kognitiva sjukdomar J Marcusson, K Blennow, I Skoog, A Wallin Linköpings universitet, 2003 | 170 | 2003 |
| Dementia in primary care: why the low detection rate? M Ólafsdóttir, M Foldevi, J Marcusson Scandinavian journal of primary health care 19 (3), 194-198, 2001 | 168 | 2001 |
